Thyroid hormone use and the risk of hip fracture in women ≥ 65 years: A case-control study

Journal of Women's Health

Volumn 12, Issue 1, 2003, Pages 27-31

  Van den Eeden, Stephen K ^a   Barzilay, Joshua I ^b   Ettinger, Bruce ^a   Minkoff, Jerome ^b  

^a DIVISION OF RESEARCH   (United States)

^b KAISER PERMANENTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN; STEROID; THIAZIDE DIURETIC AGENT; THYROID HORMONE;

AGED; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG USE; FALLING; FEMALE; HIP FRACTURE; HOSPITALIZATION; HUMAN; HYPOTHYROIDISM; MAJOR CLINICAL STUDY; MANAGED CARE ORGANIZATION; OSTEOPOROSIS; PRIORITY JOURNAL; RISK ASSESSMENT; TREATMENT OUTCOME; UNITED STATES; VISUAL IMPAIRMENT;

EID: 0345382663     PISSN: 15409996     EISSN: None     Source Type: Journal    
DOI: 10.1089/154099903321154112     Document Type: Article

References (22)

1. Kaufman SC, Gross TP, Kennedy DL. Thyroid hormone use: Trends in the United States from 1960 through 1988. Thyroid 1991;1:285.
2. Simonsen LLP. What are pharmacists dispensing most often? Pharm Times 1993;59:29.
3. Uzzan B, Campos J, Cucherat M, Nony P, Boissel JP, Perret GY. Effects on bone mass of long-term treatment with thyroid hormones: A meta-analysis. J Clin Endocrinol Metab 1996;81:4287.
4. Greenspan SL, Greenspan FS. The effect of thyroid hormone on skeletal integrity. Ann Intern Med 1999;130:750.
5. Stock JM, Surks MI, Oppenheimer JH. Replacement dosage of L-thyroxine in hypothyroidism. A re-evaluation. N Engl J Med 1974;290:529.
6. Evered D, Young ET, Ormston BJ, Menzies R, Smith PA, Hall R. Treatment of hypothyroidism: A reappraisal of thyroxine therapy. Br Med J 1973;3:131.
7. Breslow NE, Day NE. Statistical methods in cancer research. Vol 1. The analysis of case-control studies. Lyon: International Agency for Research on Cancer, 1980.
8. Rothman KJ, Greenland S. Modern epidemiology, 2nd ed. Philadelphia: Lippincott-Raven, 1998.
9. Sheppard MC, Holder R, Fraklyn JA. Levothyroxine treatment and occurrence of fracture of the hip. Arch Intern Med 2002;162:338.
10. Solomon BL, Wartofsky L, Burman KD. Prevalence of fractures in postmenopausal women with thyroid disease. Thyroid 1993;3:17.
11. Leese GP, Jung RT, Guthrie C, Waugh N, Browing MCK. Morbidity in patients on L-thyroxine: A comparison of those with a normal TSH to those with a suppressed TSH. Clin Endocrinol (Oxf) 1992;37:500.
12. Bauer DC, Ettinger B, Nevitt MC, Stone KL, for the Osteoporotic Fractures Research Group. Risk for fracture in women with low serum levels of thyroid-stimulating hormone. Ann Intern Med 2001;134:561.
13. Wejda B, Hintze G, Katschinski B, Olbricht T, Benker G. Hip fractures and the thyroid: A case-control study. J Intern Med 1995;237:241.
14. Taelman P, Kaufman JM, Janssens X, Vandecauter H, Vermeulen A. Reduced forearm bone mineral content and biochemical evidence of increased bone turnover in women with euthyroid goiter treated with thyroid hormone. Clin Endocrinol (Oxf) 1990;33:107.
15. Pioli G, Pedrazzoni M, Palummeri E, et al. Longitudinal study of bone loss after thyroidectomy and suppressive thyroxine therapy in premenopausal women. Acta Endocrinol (Copenh) 1992;126:238.
16. Kung AWC, Pun K. Bone mineral density in premenopausal women receiving long-term physiological doses of levothyroxine. JAMA 1991;265:2688.
17. Adlin EV, Maurer AH, Marks AD, Channick BJ. Bone mineral density in postmenopausal women treated with L-thyroxine. Am J Med 1992;90:360.
18. Gam AN, Jensen GF, Hasselstrom K, Olsen M, Siersbaek Nielson K. Effect of thyroxine therapy on bone metabolism in substituted hypothyroid patients with normal or suppressed levels of TSH. J Endocrinol Invest 1991;14:451.
19. Luukinen H, Herala M, Koski K, Honkanen R, Laippala P, Kivela SL. Fracture risk associated with a fall according to type of fall among the elderly. Osteoporosis Int 2000;11:631.
20. Gallagher JC, Melton LJ, Riggs BL. Examination of prevalence rates of possible risk factors in a population with a fracture of the proximal femur. Clin Orthop 1980;153:158.
21. Ivers RQ, Norton R, Cumming RG, Butler M, Campbell AJ. Visual impairment and risk of hip fracture Am J Epidemiol 2000;152:633.
22. Cummings SR, Nevitt MC, Browner WS, et al., for the Study of Osteoporotic Fractures Research Group. Risk factors for hip fracture in white women. N Engl J Med 1995;332:767.